Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaLeukemia, LymphoidLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, AcuteAsparaginaseMyeloid-Lymphoid Leukemia ProteinLeukemia, MyeloidAcute DiseaseCytarabineGene Expression Regulation, LeukemicLeukemia, Biphenotypic, AcuteTranslocation, GeneticBone MarrowRemission InductionLeukemia, B-Cell6-MercaptopurinePrognosisPrecursor B-Cell Lymphoblastic Leukemia-LymphomaMethotrexateLeukemia-Lymphoma, Adult T-CellDaunorubicinVincristineKaryotypingBurkitt LymphomaAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemic InfiltrationLeukemia, T-CellChromosome AberrationsLeukemia, Monocytic, AcuteDNA, NeoplasmRemission, SpontaneousChromosomes, Human, Pair 11ImmunophenotypingRecurrenceNeoplasm ProteinsB-LymphocytesCore Binding Factor Alpha 2 SubunitGene RearrangementBlast CrisisOncogene Proteins, FusionPhiladelphia ChromosomeProto-OncogenesLeukemia, ExperimentalTreatment OutcomeVidarabineNeoplasm, ResidualSurvival AnalysisDrug Resistance, NeoplasmTumor Cells, CulturedFlow CytometryImmunoglobulin Heavy ChainsSurvival RateMutationPrednisoneLymphomaLymphocytes, NullDNA NucleotidylexotransferaseAntigens, NeoplasmBase SequenceChromosomes, Human, Pair 9Receptors, Antigen, B-CellDisease-Free SurvivalCyclophosphamideRisk FactorsPolymerase Chain Reactionfms-Like Tyrosine Kinase 3Cyclin-Dependent Kinase Inhibitor p15Fusion Proteins, bcr-ablMolecular Sequence DataProto-Oncogene ProteinsLeukemia, Hairy CellBone Marrow TransplantationZAP-70 Protein-Tyrosine KinaseT-LymphocytesLymphocytesArabinonucleosidesCell Transformation, NeoplasticChlorambucilRosette FormationChromosomes, Human, Pair 12Neoplastic Stem CellsDrug Administration ScheduleDual Specificity Phosphatase 2Chromosomes, Human, 6-12 and XCytogenetic AnalysisTime FactorsCell Line, TumorAntibodies, MonoclonalRetrospective StudiesLeukemia Virus, MurineApoptosisTranscription FactorsMitoxantroneAnisocoriaDNA-Binding ProteinsDexamethasoneChromosome Disorders